NeuroPace Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for NeuroPace, Inc. (NPCE) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents13.4318.0677.41115.5826.39
Short-Term Investments39.3348.4070.8096.4011.69
Cash & Short-Term Investments52.7666.4577.41115.5838.08
Accounts Receivable12.8512.317.487.098.40
Inventory13.3811.219.717.826.91
Other Current Assets2.352.741.60-5.241.18
Total Current Assets81.3492.7297.71132.8254.56
Non-Current Assets
Property, Plant & Equipment (Net)12.9014.4115.900.600.52
Other Non-Current Assets0.410.140.140.140.39
Total Non-Current Assets13.3114.9316.350.750.00
Total Assets94.65107.65114.11133.5655.95
Current Liabilities
Accounts Payable2.952.339.569.300.95
Short-Term Debt3.720.000.000.000.00
Accrued Liabilities9.7911.187.417.435.94
Deferred Revenue0.561.090.000.000.00
Other Current Liabilities7.939.665.756.550.67
Total Current Liabilities15.1616.2310.989.309.60
Non-Current Liabilities
Long-Term Debt71.4856.9568.3549.8550.82
Other Non-Current Liabilities0.000.000.000.911.58
Total Non-Current Liabilities71.4870.7768.3550.760.00
Total Liabilities86.6387.0079.3360.0661.99
Stockholders' Equity
Common Stock0.030.030.030.020.00
Retained Earnings-530.95-503.81-471.96-424.04-387.69
Accumulated Other Comprehensive Income0.000.00-1.11-0.270.03
Additional Paid-in Capital538.93524.44506.71497.520.00
Shares Outstanding30.1527.8225.0524.450.00
Total Stockholders' Equity8.0120.6534.7873.50-6.04
Total Liabilities & Equity94.65107.65114.11133.560.00